Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Make the right choices and you will succeed, Prof Jansen advises learners
2014-05-30

“You can make a choice today that will end up with you being pregnant, having babies, being unemployed, sitting at home like some of our brothers and sisters, uncles and aunts. Or you can make a different decision – and that decision is about you working so hard that you earn entry into the University of the Free State, get your degree and become great, not only in South Africa, but in the world.”

This was the message from the UFS’s Vice-Chancellor and Rector, Prof Jonathan Jansen, who addressed prospective Kovsies during our Open Day on the Qwaqwa Campus on Saturday 24 May 2014. Prof Jansen advised all learners to always make the right decisions.

“The first right decision is to pass well. You must go for 60%, 70% and 80% passes. Set yourself a target and do not just strive to pass, but to pass well,” Prof Jansen told a packed Rolihlahla Mandela Multi-purpose Hall, with learners coming from as far as Ficksburg, Lindley and Koppies.

“The second thing that you need to do, is to believe in yourself. Do not believe people who tell you what you can or cannot do. Believe in what you can do,” said Prof Jansen.

“Thirdly, you have to get up and do things for yourself. You have to work hard, sleep less and study hard. Don't accept excuses. If you can do these three things, then the best place to study is the University of the Free State. Believe that the sky is the limit.”

“We learned a very valuable lesson here today,” said Tumelo Mofokeng from Nkarabeng Secondary School in Kestell.

The fun-filled programme included performances and messages of encouragement from current students who have been part of the unique Leadership for Change Programme. This programme equips first-year students with skills to reflect, dialogue and engage on issues of diversity and leadership.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept